Metabolic syndrome as a modifier of atherosclerosis in murine models.

Metabolic syndrome as a modifier of atherosclerosis in murine models. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Metabolic syndrome as a modifier of atherosclerosis in murine models. Abstract Text:

,Richard C Davis,Aldons J Lusis,Miklós Péterfy,Richard C Davis,Aldons J Lusis,

The Metabolic Syndrome is a common metabolic disease associated with an increased risk for atherosclerotic cardiovascular disease and mortality. In contrast to "traditional" risk factors for atherosclerosis, such as low-density lipoprotein cholesterol, the Metabolic Syndrome represents a network of interacting risk factors stemming from the metabolic complexity of this disease. For this reason, dissection of the cellular and molecular pathways underlying atherosclerosis-susceptibility in the Metabolic Syndrome has been difficult. To facilitate this endeavor, several murine models have been recently developed. Despite their imperfect representation of the Metabolic Syndrome and atherosclerosis in humans, these models have provided important mechanistic insights and revealed novel molecular pathways. Furthermore, murine models are invaluable for the evaluation of therapeutic approaches and will no doubt facilitate the genetic dissection of atherosclerosis-susceptibility in the Metabolic Syndrome.

Metabolic syndrome as a modifier of atherosclerosis in murine models. Publishing Authors By Initials

M ,RC Davis,AJ Lusis,M Péterfy,RC Davis,AJ Lusis,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Metabolic syndrome as a modifier of atherosclerosis in murine models. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Current drug targets

VOLUME: 8

Page Numbers: 1215-20

Journal Abbreviation:

ISSN: 1873-5592

DAY: 29

MONTH: Nov

YEAR: 2007

Metabolic syndrome as a modifier of atherosclerosis in murine models. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100960531

Metabolic syndrome as a modifier of atherosclerosis in murine models. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Metabolic syndrome as a modifier of atherosclerosis in murine models. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Metabolic syndrome as a modifier of atherosclerosis in murine models.

AFFILIATION: Department of Medicine, UCLA School of Medicine, Los Angeles, CA 90073, USA. mpeterfy@ucla.edu

Country: Netherlands

AGENCY: United States NHLBI

GRANT: HL28481

ACRONYM: HL

MEDLINETA: Curr Drug Targets

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Metabolic syndrome as a modifier of atherosclerosis in murine models Related Publications

• A genome-wide set of congenic mouse strains derived from CAST/Ei on a C57BL/6 background.
• Apolipoprotein A-II: a protein in search of a function.
• Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance.
• Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia.
• Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions.
• High-resolution mapping of gene expression using association in an outbred mouse stock.
• Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics.
• Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data.
• Integrating genetic and gene expression data: application to cardiovascular and metabolic traits in mice.
• Integrating global gene expression analysis and genetics.
• Linkage between the APOB gene and serum ApoB levels in a large pedigree from the Bogalusa Heart Study.
• Localization of the mouse glucocorticoid receptor-interacting protein 1 gene (Grip1) to proximal chromosome 1 by linkage analysis.
• Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice.
• Metabolic syndrome as a modifier of atherosclerosis in murine models.
• Network-centered view of coronary artery disease.
• Trypanosoma congolense: paraoxonase 1 prolongs survival of infected mice.